NCT06074107
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
Clinical trial condition
Relapsed or Refractory Diffuse Large B-cell Lymphoma
Explore clinical trials studying Relapsed or Refractory Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Relapsed or Refractory Diffuse Large B-cell Lymphoma trial results
NCT05144841
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- St. Joseph Hospital-The Center for Cancer Prevention and Treatment ( Site 0229) Orange, California, United States
- Innovative Clinical Research Institute ( Site 0202) Whittier, California, United States
- Georgetown University Medical Center ( Site 0204) Washington D.C., District of Columbia, United States
- Northside Hospital ( Site 0206) Atlanta, Georgia, United States
NCT04049825
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Yamagata University Hospital Yamagata, Japan